Research funder · Australia
Phenomics Australia
- Grants since 2016
- 70
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 0
- Funded works, all time
- 0
Grants
2026
Validating the generalizability of artificial intelligence for in silico drug combination prediction
2026
Development of human GPCR knock-in mice for assessment of therapeutic antibodies
2026
Establishing a targeted treatment strategy using epigenetic reprogramming against adverse EMT-induced tumour plasticity in head and neck (oral) squamous cell carcinoma
2026
Transcriptomic and phenotypic screening of aged human microtissues to advance Alzheimer's disease therapeutics
2026
High throughput screening of micro-organoids for assessing heterogeneity and precision medicine potential in endometriosis
2026
Developing rapid Pharmacodynamic AURKA Targeted Protein Degrader screening mice
2026
Development of an epicardial lineage tracing human pluripotent stem cell line to identify new cardiac therapeutics
2026
Developing a human iPSC-derived alveolar coculture platform to model respiratory infection and regeneration
2026
Deciphering the role of the kinome in skeletal muscle and their potential use as a therapeutic target in disease
2026
Overcoming Silence in Neurodevelopmental Disorder Gene Diagnosis
2026
Patient-Derived Cortical Organoids to Decipher Disease Mechanisms and Therapeutic Response in SLC6A1-Related NDD
2026
Patient-derived iPSC airway epithelial assay systems to develop Jagged-1 inhibitors targeting the root cause of muco-obstructive lung diseases
2026
Understanding the genetic basis of Syntelencephaly
Madeleine Lucy Maria Hardy
2026
Reprogramming the Breast Cancer Microenvironment to Improve Anti-Tumour Immunity
2026
CRISPR-Engineered Motor Neuron Disease Cell Models to Enable Target Validation and Accelerate Therapeutic Translation
2026
Creating an immunocompetent preclinical prostate cancer model to investigate targeting a tumour-driving transcription factor to stop disease
2026
Personalised treatment strategies for patients with early-onset metastatic colorectal cancer
2026
Determining the role of endometrial dysfunction in endometriosis
2026
Evaluating human organoids as model systems in drug development
2026
Generating a model of variations in female reproductive tract development using a new stem cell reporter line
2026
A chloride ion channel as a novel therapeutic target for ischaemic heart disease
2026
Next-generation CRISPR therapeutics for autosomal dominant retinitis pigmentosa
2025
Generation of a human stem cell model to screen for efficacy and potency of novel regenerative small molecules
2025
Development of a high-throughput lung epithelial cell screening platform for discovery of broadly-acting antivirals against coronaviruses
2025
A multi-omics strategy to reveal hidden genetic drivers in undiagnosed gonadal dysgenesis
2025
Genome-Scale Functional Screen to Discover Therapeutic Targets for Muscle Atrophy and Regeneration
2025
Generating a murine model of genetic prion disease relevant to Australian mutation carriers
2025
Developing an inducible mouse model of neonatal encephalopathy for preclinical evaluation of sodium channel modulators
2025
Investigating the potential of differentiation therapy for paediatric diffuse hemispheric glioma
2025